News

microphotonX appoints Dr. Lars Behrend as new CEO



microphotonX GmbH, a biophotonic startup based in Tutzing, is expanding its management team. Dr. Lars Behrend came on board in April 2022 and is managing the business together with Dr. Hesham Yosef (application development) and Dr. Tilo Zollitsch (technical development). Lars, who holds a PhD in biology, will contribute his experience from 16 years of experience in start-up support and the investment business. He was successfully involved in establishing and developing the high-tech companies Sirion Biotech GmbH and Siqens GmbH. Larsalso brings experience from clinical research and will accompany the novel technology platform on its path into the regulated market. The Biospex Analyser from microphotonX is the first product that can perform Raman spectral analysis of living cells directly in liquid biopsies. To achieve this, the company combined Raman spectroscopy with laser trapping, allowing single cell analysis without affecting the physiology of the cell. The novel technology is called Raman Single Beam Trapping (Raman SBT) and is protected by extensive international patents. microphotonX has already placed several devices on the market and is currently working on applications with cooperation partners such as Borstel Research Center, the Federal Office for Risk Assessment, and the University of Erlangen.